Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection

Condition:   Renal Transplant Rejection Intervention:   Drug: Fostamatinib Sponsor:   Imperial College London Recruiting

Source: ClinicalTrials.gov - June 19, 2019 Category: Research Source Type: clinical trials